ASN003: Ph I started
Asana began an open-label, U.S. Phase I trial to evaluate ASN003 in about 100 patients. A dose-escalation part will determine the dose for the expansion cohort in the second part, which will enroll patients with...
About Biocentury
Contact
Support
Products & Solutions
Legal
- Follow Us
